Community Medicine (PSM) · Communicable Diseases (Malaria, Tuberculosis, Dengue, Polio, Hepatitis, Cholera)

A 25-year-old woman is diagnosed with smear-positive pulmonary tuberculosis. She is started on Category I DOTS therapy under the Revised National Tuberculosis Control Programme (RNTCP)/National Tuberculosis Elimination Programme (NTEP). Which of the following correctly describes the intensive phase of her treatment?

  • A 2 months of Isoniazid, Rifampicin, Streptomycin (2HRS)
  • B 2 months of Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (2HRZE)
  • C 4 months of Isoniazid and Rifampicin (4HR)
  • D 6 months of Isoniazid, Rifampicin, Pyrazinamide (6HRZ)
Correct answer: B. 2 months of Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (2HRZE)

Explanation

Under NTEP, the standard first-line treatment for new TB cases (previously Category I) consists of an intensive phase of 2 months with four drugs: Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), and Ethambutol (E) — written as 2HRZE. This is followed by a continuation phase of 4 months with Isoniazid and Rifampicin (4HR). All drugs are given as fixed-dose combinations (FDCs) daily under direct observation.

Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Communicable Diseases (Malaria, Tuberculosis, Dengue, Polio, Hepatitis, Cholera) MCQs

See all Communicable Diseases (Malaria, Tuberculosis, Dengue, Polio, Hepatitis, Cholera) MCQs →